{"target": "https://www.ncbi.nlm.nih.gov/research/pubtator-api/publications/export/biocjson?pmids=12668759", "sourcedb": "PubMed", "sourceid": "12668759", "text": "Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis. Therapeutic vaccination with Copaxone (glatiramer acetate, Cop-1) protects motor neurons against acute and chronic degenerative conditions. In acute degeneration after facial nerve axotomy, the number of surviving motor neurons was almost two times higher in Cop-1-vaccinated mice than in nonvaccinated mice, or in mice injected with PBS emulsified in complete Freund's adjuvant (P &lt; 0.05). In mice that express the mutant human gene Cu/Zn superoxide dismutase G93A (SOD1), and therefore simulate the chronic human motor neuron disease amyotrophic lateral sclerosis, Cop-1 vaccination prolonged life span compared to untreated matched controls, from 211 +/- 7 days (n = 15) to 263 +/- 8 days (n = 14; P &lt; 0.0001). Our studies show that vaccination significantly improved motor activity. In line with the experimentally based concept of protective autoimmunity, these findings suggest that Cop-1 vaccination boosts the local immune response needed to combat destructive self-compounds associated with motor neuron death. Its differential action in CNS autoimmune diseases and neurodegenerative disorders, depending on the regimen used, allows its use as a therapy for either condition. Daily administration of Cop-1 is an approved treatment for multiple sclerosis. The protocol for non-autoimmune neurodegenerative diseases such as amyotrophic lateral sclerosis, remains to be established by future studies.", "project": "Standigm_training", "denotations": [{"id": "T0", "span": {"begin": 34, "end": 63}, "obj": "DISEASE"}, {"id": "T1", "span": {"begin": 82, "end": 111}, "obj": "DISEASE"}, {"id": "T10", "span": {"begin": 520, "end": 527}, "obj": "REG"}, {"id": "T13", "span": {"begin": 583, "end": 587}, "obj": "PROTEIN"}, {"id": "T14", "span": {"begin": 652, "end": 681}, "obj": "DISEASE"}, {"id": "T15", "span": {"begin": 683, "end": 688}, "obj": "GENE"}, {"id": "T16", "span": {"begin": 701, "end": 710}, "obj": "POSREG"}, {"id": "T17", "span": {"begin": 711, "end": 720}, "obj": "CPA"}, {"id": "T18", "span": {"begin": 881, "end": 889}, "obj": "POSREG"}, {"id": "T19", "span": {"begin": 890, "end": 904}, "obj": "CPA"}, {"id": "T20", "span": {"begin": 1008, "end": 1013}, "obj": "GENE"}, {"id": "T21", "span": {"begin": 1026, "end": 1032}, "obj": "POSREG"}, {"id": "T22", "span": {"begin": 1043, "end": 1058}, "obj": "CPA"}, {"id": "T24", "span": {"begin": 1328, "end": 1333}, "obj": "GENE"}, {"id": "T25", "span": {"begin": 1363, "end": 1381}, "obj": "DISEASE"}, {"id": "T26", "span": {"begin": 1450, "end": 1479}, "obj": "DISEASE"}, {"id": "T4", "span": {"begin": 172, "end": 177}, "obj": "GENE"}, {"id": "T8", "span": {"begin": 317, "end": 340}, "obj": "CPA"}, {"id": "T9", "span": {"begin": 362, "end": 368}, "obj": "POSREG"}, {"id": "T27", "span": {"begin": 631, "end": 651}, "obj": "DISEASE"}, {"id": "T28", "span": {"begin": 532, "end": 581}, "obj": "VAR"}], "relations": [{"id": "R1", "pred": "ThemeOf", "subj": "T8", "obj": "T9"}, {"id": "R6", "pred": "ThemeOf", "subj": "T17", "obj": "T16"}, {"id": "R7", "pred": "ThemeOf", "subj": "T19", "obj": "T18"}, {"id": "R8", "pred": "ThemeOf", "subj": "T22", "obj": "T21"}, {"id": "R9", "pred": "ThemeOf", "subj": "T20", "obj": "T21"}, {"id": "R10", "pred": "ThemeOf", "subj": "T13", "obj": "T28"}, {"id": "R11", "pred": "ThemeOf", "subj": "T28", "obj": "T10"}], "attributes": [], "modifications": [], "config": {"entity types": [{"id": "DISEASE", "default": true}, {"id": "REG"}, {"id": "PROTEIN"}, {"id": "GENE"}, {"id": "POSREG"}, {"id": "CPA"}, {"id": "VAR"}], "relation types": [{"id": "ThemeOf", "default": true}]}}